TNF/TNFR1 axis restrains inflammation-suppressive myeloid subclusters to drive acute pancreatitis.
7 affiliations
- 1Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- 2Postdoctoral Innovation Practice Base, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- 3Huankui Academy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- 4Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. [email protected].
- 5Postdoctoral Innovation Practice Base, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. [email protected].
- 6Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. [email protected].
- 7Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. [email protected].
Abstract
Acute pancreatitis (AP) is a pancreatic inflammatory disorder that can progress to fatal systemic inflammation and multiorgan failure. Although tumor necrosis factor (TNF) signaling is a key regulator of inflammation, its contribution to AP progression and its therapeutic potential remain incompletely understood. We induced AP in wild-type and Tnfr1-/- mice using caerulein, pancreatic duct ligation, or L-arginine. Single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing were used to characterize pancreatic immune-cell profiles, and pomalidomide, infliximab, and necrostatin-1 were evaluated as pharmacological interventions targeting the TNF/TNFR1 pathway. Analysis of public scRNA-seq datasets revealed activation of the TNF/TNFR1 axis across three AP models, accompanied by increased TNF-α and TNFR1 expression. Tnfr1 deletion markedly attenuated pancreatic injury and inflammatory-cell infiltration. scRNA-seq of pancreatic tissues further revealed substantial remodeling of the immune landscape in Tnfr1-/- mice, including reductions in myeloid cells and neutrophils. Within the Neu_C3 neutrophil subset, NF-κB and TNF signaling and neutrophil extracellular trap formation were suppressed. Integrated analysis with bulk RNA-seq showed reduced expression of Marcksl1, Ifit3, and Oas3 in the Neu_C3 cluster, with further reductions following TNFR1 ablation. Tnfr1 deletion also reduced M1 macrophage polarization and expanded an Igkc-high myeloid subcluster characterized by suppressed chemokine signaling. Among the three compounds tested, pomalidomide showed the strongest preventive and therapeutic effects across the experimental AP models. Together, these findings indicate that the TNF/TNFR1 axis promotes AP by shaping inflammatory myeloid-cell states. Targeting this pathway, particularly with pomalidomide, may provide a therapeutic strategy for AP by remodeling immune-cell populations and suppressing inflammation.
Related
- 68 Translational PET imaging of suppressive granulocytic myeloid cells in glioblastoma
- The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis
- Integrated multi-omic analysis characterizes an IFNγ-responsive-to-myeloid-suppressive immune continuum in immune-active hepatocellular carcinoma
- Keratinocyte TMEM79 protects early life epidermal homeostasis and restrains STING-dependent skin inflammation
- Disease-associated myeloid states in cardiac remodeling: A new era of cardiac inflammation research enabled by computational biology.
BibTeX
@article{zheng2026tnftnfr1,
title = {{TNF/TNFR1 axis restrains inflammation-suppressive myeloid subclusters to drive acute pancreatitis.}},
author = {Pan Zheng and Xueyang Li and Yuman Ye and Yaoyu Zou and Maobin Kuang and Jingwen Gao and Dongni Fu and Jianhua Wan and Cong He and Nonghua Lu and Xiaoli Xi and Nianshuang Li and Yin Zhu},
journal = {Cell death \& disease},
year = {2026},
month = aug,
doi = {10.1038/s41419-026-09208-9},
url = {https://europepmc.org/article/MED/42919850},
note = {CC BY},
}
RIS
TY - JOUR
TI - TNF/TNFR1 axis restrains inflammation-suppressive myeloid subclusters to drive acute pancreatitis.
AU - Pan Zheng
AU - Xueyang Li
AU - Yuman Ye
AU - Yaoyu Zou
AU - Maobin Kuang
AU - Jingwen Gao
AU - Dongni Fu
AU - Jianhua Wan
AU - Cong He
AU - Nonghua Lu
AU - Xiaoli Xi
AU - Nianshuang Li
AU - Yin Zhu
PY - 2026
DA - 2026/08/01
JO - Cell death & disease
DO - 10.1038/s41419-026-09208-9
UR - https://europepmc.org/article/MED/42919850
AB - Acute pancreatitis (AP) is a pancreatic inflammatory disorder that can progress to fatal systemic inflammation and multiorgan failure. Although tumor necrosis factor (TNF) signaling is a key regulator of inflammation, its contribution to AP progression and its therapeutic potential remain incompletely understood. We induced AP in wild-type and Tnfr1-/- mice using caerulein, pancreatic duct ligation, or L-arginine. Single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing were used to characterize pancreatic immune-cell profiles, and pomalidomide, infliximab, and necrostatin-1 were evaluated as pharmacological interventions targeting the TNF/TNFR1 pathway. Analysis of public scRNA-seq datasets revealed activation of the TNF/TNFR1 axis across three AP models, accompanied by increased TNF-α and TNFR1 expression. Tnfr1 deletion markedly attenuated pancreatic injury and inflammatory-cell infiltration. scRNA-seq of pancreatic tissues further revealed substantial remodeling of the immune landscape in Tnfr1-/- mice, including reductions in myeloid cells and neutrophils. Within the Neu_C3 neutrophil subset, NF-κB and TNF signaling and neutrophil extracellular trap formation were suppressed. Integrated analysis with bulk RNA-seq showed reduced expression of Marcksl1, Ifit3, and Oas3 in the Neu_C3 cluster, with further reductions following TNFR1 ablation. Tnfr1 deletion also reduced M1 macrophage polarization and expanded an Igkc-high myeloid subcluster characterized by suppressed chemokine signaling. Among the three compounds tested, pomalidomide showed the strongest preventive and therapeutic effects across the experimental AP models. Together, these findings indicate that the TNF/TNFR1 axis promotes AP by shaping inflammatory myeloid-cell states. Targeting this pathway, particularly with pomalidomide, may provide a therapeutic strategy for AP by remodeling immune-cell populations and suppressing inflammation.
SN - 2041-4889
ER -